Your browser doesn't support javascript.
loading
Varicella-zoster virus reactivation is frequently detected in HIV-infected individuals presenting with stroke.
Marais, Gert; Naidoo, Michelle; McMullen, Kate; Stanley, Alan; Bryer, Alan; van der Westhuizen, Diederick; Bateman, Kathleen; Hardie, Diana Ruth.
  • Marais G; Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa.
  • Naidoo M; National Health Laboratory Service, Groote Schuur Hospital, Cape Town, Western Cape, South Africa.
  • McMullen K; Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa.
  • Stanley A; National Health Laboratory Service, Groote Schuur Hospital, Cape Town, Western Cape, South Africa.
  • Bryer A; Department of Medicine, Division of Neurology, University of Cape Town, Cape Town, Western Cape, South Africa.
  • van der Westhuizen D; Department of Neurology, Hawke's Bay Fallen Soldiers Memorial Hospital, Hastings, New Zealand.
  • Bateman K; Department of Medicine, Division of Neurology, University of Cape Town, Cape Town, Western Cape, South Africa.
  • Hardie DR; National Health Laboratory Service, Groote Schuur Hospital, Cape Town, Western Cape, South Africa.
J Med Virol ; 94(6): 2675-2683, 2022 06.
Article en En | MEDLINE | ID: mdl-35133008
ABSTRACT
Infections are an underappreciated cause of stroke, particularly in young and immunocompromised individuals. Varicella-zoster virus (VZV) reactivation, particularly ophthalmic zoster, has been linked to increased risk of stroke but diagnosing VZV-associated cerebral vasculopathy is challenging as neither a recent zoster rash, nor detectable levels of VZV DNA are universally present at stroke presentation. Detection of VZV IgG in cerebrospinal fluid (CSF-VZVG) presents a promising alternative, but requires evaluation of individual blood-CSF dynamics, particularly in the setting of chronic inflammatory states such as HIV infection. Consequently, its use has not been broadly adopted as simple diagnostic algorithms are not available. In this study looking at young adults presenting with acute stroke, we used an algorithm that includes testing for both VZV nucleic acids and CSF-VZVG which was corrected for blood-CSF barrier dynamics and poly-specific immune activation. We found that 13 of 35 (37%), including 7 with a positive CSF VZV PCR, young HIV-infected adults presenting with stroke, 3 of 34 (9%) young HIV-uninfected adults presenting with stroke, and 1 of 18 (6%) HIV-infected nonstroke controls demonstrated evidence of central nervous system reactivation of VZV.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Accidente Cerebrovascular / Herpes Zóster Tipo de estudio: Diagnostic_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Accidente Cerebrovascular / Herpes Zóster Tipo de estudio: Diagnostic_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article